You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)

Showing 1 - 25 of 1,408
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir

Not yet recruiting
  • HIV
  • Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
  • Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
  • (no location specified)
Nov 13, 2023

HIV Trial in Johannesburg, Kampala, Harare (Oral cabotegravir (CAB), CAB LA, Oral tenofovir disoproxil fumarate/emtricitabine

Active, not recruiting
  • HIV Infections
  • Oral cabotegravir (CAB)
  • +2 more
  • Johannesburg, Gauteng, South Africa
  • +2 more
Dec 13, 2022

Bone Mineral Density Substudy - An Ancillary Study to MTN-003

Completed
  • HIV Infections
  • Emtricitabine/tenofovir disoproxil fumarate
  • +3 more
  • Kampala, Uganda
  • +3 more
Oct 28, 2021

Hiv, Prophylaxis, Transgender Trial in Baltimore (Truvada alone, Truvada plus Leuprolide, Truvada plus Estradiol 1 mg)

Recruiting
  • Hiv
  • +2 more
  • Truvada alone
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins School of Medicine Drug Development Unit
Mar 8, 2022

HIV/AIDS, Adherence, Medication, Drug Use Trial in Norfolk (Tenofovir Disoproxil Fumarate)

Completed
  • HIV/AIDS
  • +2 more
  • Tenofovir Disoproxil Fumarate
  • Norfolk, Virginia
    Clinical Research Center, Eastern Virginia Medical School
Apr 12, 2022

HIV Prevention Trial in Galveston (Tenofovir Disoproxil Fumarate (TDF)-Emtricitabine (FTC), Placebo)

Active, not recruiting
  • HIV Prevention
  • Tenofovir Disoproxil Fumarate (TDF)-Emtricitabine (FTC)
  • Placebo
  • Galveston, Texas
    University of Texas Medical Branch
Apr 20, 2022

Pregnancy, HIV-1-infection Trial (Standard dose Truvada®, Pregnancy-adjusted dose Truvada®)

Withdrawn
  • Pregnancy
  • HIV-1-infection
  • Standard dose Truvada®
  • Pregnancy-adjusted dose Truvada®
  • (no location specified)
Mar 28, 2022

Aicardi Goutières Syndrome Trial in Philadelphia (Tenofovir (TDF) and Emtricitabine (FTC), Placebo)

Not yet recruiting
  • Aicardi Goutières Syndrome
  • Tenofovir (TDF) and Emtricitabine (FTC)
  • Placebo
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Feb 8, 2022

Unsafe Sex, Risk-Taking Trial in Paris (Experimental: doxycycline, Bexsero® vaccine)

Recruiting
  • Unsafe Sex
  • Risk-Taking
  • Experimental: doxycycline
  • Bexsero® vaccine
  • Paris, France
  • +8 more
Mar 16, 2021

HIV Trial in United States (Cabotegravir (CAB) tablet, CAB LA, Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) tablet)

Active, not recruiting
  • HIV Infections
  • Cabotegravir (CAB) tablet
  • +2 more
  • Aurora, Colorado
  • +3 more
Feb 17, 2022

HIV Infection Trial in Puerto Rico, United States (Maraviroc, Emtricitabine, Tenofovir disoproxil fumarate)

Completed
Has Results
  • HIV Infection
  • Los Angeles, California
  • +12 more
Nov 3, 2021

HIV Trial in Worldwide (Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF), Behavioral HIV risk reduction package)

Recruiting
  • HIV Infections
  • Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
  • Behavioral HIV risk reduction package
  • Blantyre, Malawi
  • +6 more
Jun 20, 2022

HIV Trial in Johannesburg, Kampala, Chitungwiza (Dapivirine (DPV) Vaginal Ring (VR), Truvada Tablet)

Active, not recruiting
  • HIV Infections
  • Dapivirine (DPV) Vaginal Ring (VR)
  • Truvada Tablet
  • Blantyre, Malawi
  • +3 more
Feb 1, 2023

HIV Trial in Johannesburg, Kampala, Chitungwiza (Dapivirine (DPV) Vaginal Ring (VR)-004, Truvada Tablet)

Completed
  • HIV Infections
  • Dapivirine (DPV) Vaginal Ring (VR)-004
  • Truvada Tablet
  • Blantyre, Malawi
  • +3 more
Nov 17, 2022

HIV Pre-exposure Prophylaxis During Breastfeeding Trial in Thika, Kampala (FTC/TDF PrEP)

Completed
  • HIV Pre-exposure Prophylaxis During Breastfeeding
  • FTC/TDF PrEP
  • Thika, Kenya
  • +1 more
Sep 14, 2021

HIV, Fatty Liver Disease Trial in Madrid (Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day, Tenofovir disoproxil

Recruiting
  • HIV Infections
  • Fatty Liver Disease
  • Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day
  • +2 more
  • Madrid, Spain
  • +3 more
Jun 13, 2023

Antiretroviral and Related Drugs in Lactating Women and

Not yet recruiting
  • Lactating Women on Select DOI
  • +2 more
  • Botswana, Gaborone, South Africa
  • +3 more
Jan 19, 2023

HIV-1 Infection, Resistance, and Renal and Skeletal Adverse

Completed
  • HIV
    • Foster City, California
      Gilead Sciences, Inc.
    Aug 27, 2021

    Pre-Exposure Prophylaxis Trial in Indianapolis (Probenecid Oral Tablet, Tenofovir disoproxil fumarate/Emtricitabine)

    Completed
    Has Results
    • Pre-Exposure Prophylaxis
    • Probenecid Oral Tablet
    • Tenofovir disoproxil fumarate/Emtricitabine
    • Indianapolis, Indiana
      Indiana University Clinical Research Center at University Hospit
    Apr 14, 2021

    Human Immunodeficiency Virus Type 1 Trial in Worldwide (D/C/F/TAF, Boosted Protease Inhibitor (bPI), FTC/TDF)

    Completed
    Has Results
    • Human Immunodeficiency Virus Type 1
    • Phoenix, Arizona
    • +81 more
    Nov 25, 2021

    Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Tablet, Lenacapavir Injection, Emtricitabine/Tenofovir Disoproxil

    Not yet recruiting
    • Pre-Exposure Prophylaxis of HIV Infection
    • Lenacapavir Tablet
    • +2 more
    • (no location specified)
    Oct 20, 2023

    Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Injection, Lenacapavir Tablet, Emtricitabine/tenofovir disoproxil

    Not yet recruiting
    • Pre-Exposure Prophylaxis of HIV Infection
    • Lenacapavir Injection
    • +2 more
    • (no location specified)
    Oct 20, 2023

    Human Immunodeficiency Virus-type 1 Infection Trial in Worldwide (Rilpivirine, Efavirenz, Tenofovir disoproxil fumarate)

    Completed
    Has Results
    • Human Immunodeficiency Virus-type 1 Infection
    • Douala, Cameroon
    • +17 more
    Jan 22, 2021

    Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

    Completed
    • Medication Adherence
    • HIV
    • dolutegravir oral tablet 50mg
    • +3 more
    • Pittsburgh, Pennsylvania
      HIV/AIDS Clinical Research Unit / University of Pittsburgh
    Mar 2, 2022

    HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis Trial in South Africa, Uganda, United States (Islatravir, Placebo to

    Active, not recruiting
    • HIV-I
    • +2 more
    • Birmingham, Alabama
    • +23 more
    Aug 15, 2022